This volume provides the reader with a detailed overview of the current state-of-the art approach of Hepatitis C management. It reviews the course of action in handling of chronic Hepatitis C patients with various HCV genotypes and treats special cases such as acute hepatitis, transplant and renal patients as well as people who inject drugs. The two volume work on Hepatitis C introduces to the topic by reviewing virology, diagnosis, epidemiology, prevention, management and elimination of HCV. The book provides a valuable source at full length for researchers and clinicians working on Hepatitis C. …mehr
This volume provides the reader with a detailed overview of the current state-of-the art approach of Hepatitis C management. It reviews the course of action in handling of chronic Hepatitis C patients with various HCV genotypes and treats special cases such as acute hepatitis, transplant and renal patients as well as people who inject drugs.
The two volume work on Hepatitis C introduces to the topic by reviewing virology, diagnosis, epidemiology, prevention, management and elimination of HCV. The book provides a valuable source at full length for researchers and clinicians working on Hepatitis C. Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Prof. Angelos Hatzakis MD, PhD National and Kapodistrian University of Athens, Medical School Hepatitis B and C Public Policy Association
Inhaltsangabe
Assessment of liver disease severity.- Hepatitis C and autoimmunity.- Extrahepatic manifestations.- Treatment indications and pretreatment assessment.- Available agents - contraindications and potential drug-drug interactions.- Current management of patients with HCV genotype 1.- Current management of patients with HCV genotype 2.- Current management of patients with HCV genotype 3.- Current management of patients with HCV genotype 4.- Current management of patients with HCV genotype 5 or 6.- The role of RAVs in the current management of HCV.- Management of patients with HCV decompensated cirrhosis.- Management of patients with acute hepatitis C.- Management of transplant patients.- Management of immune complex-mediated manifestations of HCV.- Management of patients with co-infections (HBV, HIV).- Management of patients under hemodialysis.-Management of active drug addicts or patients on maintenance substitution.- Management of patients with hemoglobinopathies or bleeding disorders.- Follow-up during and after treatment.
Assessment of liver disease severity.- Hepatitis C and autoimmunity.- Extrahepatic manifestations.- Treatment indications and pretreatment assessment.- Available agents - contraindications and potential drug-drug interactions.- Current management of patients with HCV genotype 1.- Current management of patients with HCV genotype 2.- Current management of patients with HCV genotype 3.- Current management of patients with HCV genotype 4.- Current management of patients with HCV genotype 5 or 6.- The role of RAVs in the current management of HCV.- Management of patients with HCV decompensated cirrhosis.- Management of patients with acute hepatitis C.- Management of transplant patients.- Management of immune complex-mediated manifestations of HCV.- Management of patients with co-infections (HBV, HIV).- Management of patients under hemodialysis.-Management of active drug addicts or patients on maintenance substitution.- Management of patients with hemoglobinopathies or bleeding disorders.- Follow-up during and after treatment.
Assessment of liver disease severity.- Hepatitis C and autoimmunity.- Extrahepatic manifestations.- Treatment indications and pretreatment assessment.- Available agents - contraindications and potential drug-drug interactions.- Current management of patients with HCV genotype 1.- Current management of patients with HCV genotype 2.- Current management of patients with HCV genotype 3.- Current management of patients with HCV genotype 4.- Current management of patients with HCV genotype 5 or 6.- The role of RAVs in the current management of HCV.- Management of patients with HCV decompensated cirrhosis.- Management of patients with acute hepatitis C.- Management of transplant patients.- Management of immune complex-mediated manifestations of HCV.- Management of patients with co-infections (HBV, HIV).- Management of patients under hemodialysis.-Management of active drug addicts or patients on maintenance substitution.- Management of patients with hemoglobinopathies or bleeding disorders.- Follow-up during and after treatment.
Assessment of liver disease severity.- Hepatitis C and autoimmunity.- Extrahepatic manifestations.- Treatment indications and pretreatment assessment.- Available agents - contraindications and potential drug-drug interactions.- Current management of patients with HCV genotype 1.- Current management of patients with HCV genotype 2.- Current management of patients with HCV genotype 3.- Current management of patients with HCV genotype 4.- Current management of patients with HCV genotype 5 or 6.- The role of RAVs in the current management of HCV.- Management of patients with HCV decompensated cirrhosis.- Management of patients with acute hepatitis C.- Management of transplant patients.- Management of immune complex-mediated manifestations of HCV.- Management of patients with co-infections (HBV, HIV).- Management of patients under hemodialysis.-Management of active drug addicts or patients on maintenance substitution.- Management of patients with hemoglobinopathies or bleeding disorders.- Follow-up during and after treatment.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
